Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript

BIOCRYST PHARMACEUTICALS INC (BCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc.
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2022 SC 13G/A BlackRock Inc. reports a 8.2% stake in BIOCRYST PHARMACEUTICALS INC
04/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc.
02/16/2021 SC 13G/A CITADEL ADVISORS LLC reports a 3.8% stake in * BioCryst Pharmaceuticals, Inc.
02/16/2021 SC 13G/A Point72 Asset Management, L.P. reports a 2.1% stake in BIOCRYST PHARMACEUTICALS, INC.
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/10/2020 SC 13G/A STATE STREET CORP reports a 10.2% stake in AMENDED FILING BioCryst Pharmaceuticals Inc
02/14/2020 SC 13G/A Point72 Asset Management, L.P. reports a 5.4% stake in BIOCRYST PHARMACEUTICALS, INC.
02/14/2020 SC 13G/A RA CAPITAL MANAGEMENT, LLC reports a 0% stake in BIOCRYST PHARMACEUTICALS, INC.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc.
02/13/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/05/2020 SC 13G/A BlackRock Inc. reports a 7.9% stake in BIOCRYST PHARMACEUTICALS INC
01/22/2020 SC 13G/A INTEGRATED CORE STRATEGIES LLC reports a 6.5% stake in BIOCRYST PHARMACEUTICALS, INC.
02/14/2019 SC 13G/A RA CAPITAL MANAGEMENT, LLC reports a 9.7% stake in BIOCRYST PHARMACEUTICALS, INC.
02/13/2019 SC 13G/A BAKER BROS. ADVISORS LP reports a 13.8% stake in BioCryst Pharmaceuticals, Inc.
02/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/06/2018 SC 13G/A RA CAPITAL MANAGEMENT, LLC reports a 8.5% stake in BIOCRYST PHARMACEUTICALS, INC.
07/10/2018 SC 13G/A HENDERSON GROUP PLC reports a 11.2% stake in BIOCRYST PHARMACEUTICALS, INC.
02/14/2018 SC 13G/A RTW INVESTMENTS, LLC reports a 3.4% stake in BioCryst Pharmaceuticals, Inc.
02/14/2018 SC 13G/A Flynn James E reports a 7.3% stake in BioCryst Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy